comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 11:09:04 - browse：64

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： How to fix the rural physician shortage in the U.S.

knowledge

WSS

Listen: A conversation with researcher Kevin Esvelt on biosecurity

For longer

Altering the blood type of lungs raises potential for universal organs for transplants

Questions and answers about ramping up H5N1 bird flu vaccine

Biogen joins immunology wave with $1.15 billion acquisition of HI

Fentanyl is making it harder to start addiction treatment

focus

comprehensive

focus

How one medical school became remarkably diverse

Bird flu surveillance in wastewater gets boost from consortium

Hollywood unions extend contract negotiations for actors

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Sports medicine is finally prioritizing gender equality

Fentanyl is making it harder to start addiction treatment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Eli Lilly’s Mounjaro succeeds in second weight

ChatGPT in medicine: STAT answers readers' burning questions

H5N1 bird flu outbreak: Second human case reported, in Michigan

focus

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Senate panel passes drug pricing bills, but drops one PBM reform

ASCO eve: Let’s set the table for this year's meeting

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

entertainment

knowledge

focus

focus